CSIMarket
 


Pmv Pharmaceuticals Inc   (PMVP)
Other Ticker:  
 

Pmv Pharmaceuticals Inc 's Tangible Leverage Ratio

PMVP's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




PMVP Tangible Leverage Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Tangible Equity Change -19.62 % -18.02 % -16.21 % -14.08 % -11.93 %
Y / Y Total Liabilities Change 23.72 % 30.62 % 279.88 % 258.95 % 251.17 %
Tangible Leverage Ratio MRQ 0.09 0.09 0.08 0.07 0.06
Overall Ranking # # # # #
Seq. Tangible Equity Change -5.7 % -5.1 % -5.42 % -5.04 % -3.82 %
Seq. Total Liabilities Change 0.83 % 1.85 % 0.68 % 19.65 % 6.46 %



Tangible Leverage Ratio third quarter 2022 Comment
In Spite of the net new borrowings of 0.83% Pmv Pharmaceuticals Inc managed to improve Tangible Leverage Ratio in the third quarter 2022 to 0.09, above company's average Tangible Leverage Ratio.

Within Major Pharmaceutical Preparations industry Pmv Pharmaceuticals Inc achieved lowest Tangible Leverage Ratio. While total ranking remained unchanged compare to previous quarter at no. .

Explain Tangible Leverage Ratio?
What is PMVP Market Share?
Tangible Leverage Ratio third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Tangible Leverage Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Pmv Pharmaceuticals Inc 's Tangible Equity $ 261 Millions Visit PMVP's Balance sheet
Pmv Pharmaceuticals Inc 's Total Liabilities $ 24 Millions Visit PMVP's Balance sheet
Source of PMVP's Sales Visit PMVP's Sales by Geography


Cumulative Pmv Pharmaceuticals Inc 's Tangible Leverage Ratio

PMVP's Tangible Leverage Ratio for the trailling 12 Months

PMVP Tangible Leverage Ratio

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Tangible Equity TTM Growth -19.62 % -18.02 % -16.21 % -14.08 % -11.93 %
Y / Y Total Liabilities TTM Growth 23.72 % 30.62 % 279.88 % 258.95 % 251.17 %
Tangible Leverage Ratio TTM 0.08 0.07 0.07 0.05 0.04
Total Ranking TTM # 76 # 188 # 152 # 63 # 72
Seq. Tangible Equity TTM Growth -5.7 % -5.1 % -5.42 % -5.04 % -3.82 %
Seq. Total Liabilities TTM Growth 0.83 % 1.85 % 0.68 % 19.65 % 6.46 %


TTM Tangible Leverage Ratio Comment
On the trailing twelve months basis Due to net new borrowings of 0.83%, Tangible Leverage Ratio improved to 0.08, a new company high.
Tangible Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 34 other companies have achieved lower Tangible Leverage Ratio than Pmv Pharmaceuticals Inc . While total ranking remained unchanged compare to previous quarter at no. 76.

Explain Tangible Leverage Ratio?
What is PMVP Market Share?

TTM Tangible Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 35
Healthcare Sector # 46
Within the Market # 76


TTM Tangible Leverage Ratio Statistics
High Average Low
0.08 0.05 0.02
(Sep 30 2022)   (Mar 31 2021)




Companies with similar Tangible Leverage Ratio in the quarter ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Tangible Leverage RatioSep 30 2022 MRQ Total LiabilitiesSep 30 2022 MRQ Tangible Equity
Akouos inc   0.25 $ 44.671  Millions$ 180.838  Millions
Matinas Biopharma Holdings Inc   0.24 $ 8.379  Millions$ 34.265  Millions
Schrodinger Inc   0.24 $ 111.710  Millions$ 457.611  Millions
Corvus Pharmaceuticals Inc   0.24 $ 15.667  Millions$ 64.681  Millions
Chinook Therapeutics Inc   0.24 $ 108.390  Millions$ 449.799  Millions
Benitec Biopharma Inc   0.24 $ 3.502  Millions$ 14.613  Millions
Regeneron Pharmaceuticals Inc   0.24 $ 4,911.700  Millions$ 20,634.700  Millions
Zentalis Pharmaceuticals Inc   0.24 $ 100.689  Millions$ 425.002  Millions
Verve Therapeutics Inc   0.23 $ 125.412  Millions$ 547.943  Millions
Ocuphire Pharma Inc   0.23 $ 2.691  Millions$ 11.877  Millions
Amarin Corp Plcuk  0.22 $ 126.277  Millions$ 566.189  Millions
Erasca Inc   0.22 $ 81.110  Millions$ 365.319  Millions
Angion Biomedica Corp  0.22 $ 11.106  Millions$ 50.210  Millions
Aclaris Therapeutics Inc   0.22 $ 47.028  Millions$ 212.846  Millions
Gain Therapeutics inc  0.22 $ 4.924  Millions$ 22.663  Millions
Vera Therapeutics Inc   0.22 $ 22.963  Millions$ 105.718  Millions
Kinnate Biopharma Inc   0.22 $ 53.792  Millions$ 248.341  Millions
Virpax Pharmaceuticals Inc   0.22 $ 4.208  Millions$ 19.428  Millions
Allakos Inc   0.22 $ 74.387  Millions$ 344.179  Millions
Geovax Labs Inc   0.21 $ 6.789  Millions$ 31.781  Millions
Vincerx Pharma Inc   0.21 $ 12.669  Millions$ 59.707  Millions
Sesen Bio Inc   0.21 $ 34.695  Millions$ 165.029  Millions
Ovid Therapeutics Inc   0.21 $ 29.713  Millions$ 142.051  Millions
Neximmune Inc   0.21 $ 9.959  Millions$ 47.716  Millions
Kiniksa Pharmaceuticals Ltd   0.21 $ 75.945  Millions$ 365.508  Millions
Hcw Biologics Inc   0.21 $ 8.798  Millions$ 42.555  Millions
Viracta Therapeutics Inc   0.21 $ 14.008  Millions$ 67.812  Millions
Annexon Inc   0.20 $ 52.120  Millions$ 260.602  Millions
China Health Industries Holdings Inc   0.20 $ 7.723  Millions$ 38.618  Millions
Dyne Therapeutics Inc   0.20 $ 49.935  Millions$ 249.744  Millions

Date modified: 2022-11-10T15:51:36+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BMAQ's Profile

Stock Price

BMAQ's Financials

Business Description

Fundamentals

Charts & Quotes

BMAQ's News

Suppliers

BMAQ's Competitors

Customers & Markets

Economic Indicators

BMAQ's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071